.

Name : Ms. ALKA GUPTA

Lab No. : 176628528 Age : 58 Years
Ref By : DR RAJSHEKHAR REDDY Gender : Female
Collected : 13/1/2024 7:17:00AM Reported : 13/1/2024 1:47:00PM
A/c Status : P Report Status : Final
Collected at : LPL-H.ROAD(HOME VISIT) Processed at : LPL-NATIONAL REFERENCE LAB
DELHI, National Reference laboratory, Block E,
DELHI Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM

Cholesterol Total 101 mg/dL <200

(CHO-POD)
Triglycerides 118 mg/dL <150
(GPO-POD)
HDL Cholesterol 49 mg/dL >50
(Enz Immunoinhibition)
LDL Cholesterol,Direct 38 mg/dL <100
(Enz Selective protection)
VLDL Cholesterol 24 mg/dL <30
(Calculated)
Non-HDL Cholesterol 52 mg/dL <130
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for
Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors

ASCVD Risk Stratification & Treatment goals in Indian population

1. Indians are at very high risk of developing ASCVD, they usually get the disease at an early age,
have a more severe form of the disease and have poorer outcome as compared to the western
populations
2. Many individuals remain asymptomatic before they get heart attack, ASCVD risk helps to identify
high risk individuals even when there is no symptom related to heart disease
3. ASCVD risk category helps clinician to decide when to consider therapy and what should be the
treatment goal

Treatment Goals as per Lipid Association of India 2020

*176628528* Page 1 of 5
.

Name : Ms. ALKA GUPTA

Lab No. : 176628528 Age : 58 Years
Ref By : DR RAJSHEKHAR REDDY Gender : Female
Collected : 13/1/2024 7:17:00AM Reported : 13/1/2024 1:47:00PM
A/c Status : P Report Status : Final
Collected at : LPL-H.ROAD(HOME VISIT) Processed at : LPL-NATIONAL REFERENCE LAB
DELHI, National Reference laboratory, Block E,
DELHI Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

--------------------------------------------------------------------------------------------
| | CONSIDER THERAPY | TREATMENT GOAL |
| ASCVD RISK |-------------------------------------|----------------------------------------|
| CATEGORY@ | LDL CHOLESTEROL| NON HDL CHLOESTEROL| LDL CHOLESTEROL | NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) |(NON HDL-C) (mg/dL |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (A) | >=50 | >=80 |<50 (Indispensable)| <80 |
| | | |<30 (Optional) | |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (B) | >=30 | >=60 | <30 | <60 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Very High | >=50 | >=80 | <50 | <80 |
|--------------|----------------|--------------------|-------------------|--------------------|
| High | >=70 | >=100 | <70 | <100 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Moderate | >=100 | >=130 | <100 | <130 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Low | >=130* | >=160* | <100 | <130 |
---------------------------------------------------------------------------------------------
* In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

@To know your risk category click on bit.ly link sent on your registered mobile number, answer the
questionnaire, the ASCVD risk report can be downloaded from website

KIDNEY PANEL; KFT,SERUM

Creatinine 0.63 mg/dL 0.55 - 1.02

(Modified Jaffe,Kinetic)
GFR Estimated 102 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea 26.30 mg/dL 13.00 - 43.00
(Urease UV)
Urea Nitrogen Blood 12.28 mg/dL 6.00 - 20.00
(Calculated)
BUN/Creatinine Ratio 19
(Calculated)
Uric Acid 4.00 mg/dL 2.60 - 6.00
(Uricase)
Total Protein 7.20 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.22 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.42 0.90 - 2.00
(Calculated)

*176628528* Page 2 of 5
.

Name : Ms. ALKA GUPTA

Lab No. : 176628528 Age : 58 Years
Ref By : DR RAJSHEKHAR REDDY Gender : Female
Collected : 13/1/2024 7:17:00AM Reported : 13/1/2024 1:47:00PM
A/c Status : P Report Status : Final
Collected at : LPL-H.ROAD(HOME VISIT) Processed at : LPL-NATIONAL REFERENCE LAB
DELHI, National Reference laboratory, Block E,
DELHI Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

Globulin(Calculated) 2.98 gm/dL 2.0 - 3.5

Calcium, Total 9.50 mg/dL 8.70 - 10.40

(Arsenazo III)
Phosphorus 3.83 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 140.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 5.74 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 104.00 mEq/L 98.00 - 107.00
(Indirect ISE)

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

*176628528* Page 3 of 5
.

Name : Ms. ALKA GUPTA

Lab No. : 176628528 Age : 58 Years
Ref By : DR RAJSHEKHAR REDDY Gender : Female
Collected : 13/1/2024 7:17:00AM Reported : 13/1/2024 1:47:00PM
A/c Status : P Report Status : Final
Collected at : LPL-H.ROAD(HOME VISIT) Processed at : LPL-NATIONAL REFERENCE LAB
DELHI, National Reference laboratory, Block E,
DELHI Sector 18, Rohini, New Delhi -110085

Test Report
Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT;CBC

Hemoglobin 11.60 g/dL 12.00 - 15.00

(Photometry)
Packed Cell Volume (PCV) 35.40 % 36.00 - 46.00
(Calculated)
RBC Count 4.61 mill/mm3 3.80 - 4.80
(Electrical Impedence)
MCV 76.90 fL 83.00 - 101.00
(Electrical Impedence)
MCH 25.10 pg 27.00 - 32.00
(Calculated)
MCHC 32.60 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 17.20 % 11.60 - 14.00
(Electrical Impedence)
Total Leukocyte Count (TLC) 10.50 thou/mm3 4.00 - 10.00
(Electrical Impedence)
Differential Leucocyte Count (DLC)
(VCS Technology)
Segmented Neutrophils 69.80 % 40.00 - 80.00
Lymphocytes 19.30 % 20.00 - 40.00
Monocytes 8.50 % 2.00 - 10.00
Eosinophils 2.10 % 1.00 - 6.00
Basophils 0.30 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 7.33 thou/mm3 2.00 - 7.00
Lymphocytes 2.03 thou/mm3 1.00 - 3.00
Monocytes 0.89 thou/mm3 0.20 - 1.00
Eosinophils 0.22 thou/mm3 0.02 - 0.50
Basophils 0.03 thou/mm3 0.02 - 0.10
Platelet Count 253 thou/mm3 150.00 - 410.00
(Electrical impedence)
Mean Platelet Volume 10.0 fL 6.5 - 12.0
(Electrical Impedence)
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential

*176628528* Page 4 of 5
.

Name : Ms. ALKA GUPTA

Lab No. : 176628528 Age : 58 Years
Ref By : DR RAJSHEKHAR REDDY Gender : Female
Collected : 13/1/2024 7:17:00AM Reported : 13/1/2024 1:47:00PM
A/c Status : P Report Status : Final
Collected at : LPL-H.ROAD(HOME VISIT) Processed at : LPL-NATIONAL REFERENCE LAB
DELHI, National Reference laboratory, Block E,
DELHI Sector 18, Rohini, New Delhi -110085

Test Report
Test Name Results Units Bio. Ref. Interval
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda

MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Sr. Consultant Pathologist -
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Hematology & Immunology
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHJEIBNLGHKALNCBILLJCECCJKCIKPKNKEDFEFAPPAHEEEHA
BNFFFNBPAPBKJHMGFGECBGAPAOAHFHAKAKNOBCJKNLELNOJGMPBNFFFNB
GMDAECFNPMMKHHGNHFIAAJHFJGFEHEDPLKPHENFLMKLMOEFLBLGDEHANP
DJKFAOFNBPFIELEDLJNELEPFANHLALAFJIFFPBPAKKNJPDNLIJFBKEMEL
KAJGJLFIONJFDIABLPHGMHBDKENLKBAHKKMHAKOIPLKGKPNGKFFFOIIKD
HGCBBEFCPECAMJGKIIBEFIPBADHFOFAINCECBKDLALIKOMNALNEIOOMKL
PNIMIJFBMLOIFJDIEOIEDGEHIHAFJBAKPNGPBLMMOJCHKNFMIJNJMDILD
BNFNAMFNAJMNLMGMAANHDDEILKBMFMBFKFCCAMNNIJKDKPNGBNFMAHILL
NKLDLFFHIFCGFEILJNNIHJJKHOBFEKFBJFFKBLPFOEBIOCNKDJPHNEKLJ
MMOFOLFCELAJJDCKAPPOIDJAIDFKPNJHKEPDELHLNKCKIGEOCFPKHOGNL
GAIKNMFLGKKKNOBMPIIOMJEEINMMMNNBJNFEBFOFPNDMKPFKEPCIGKAMG
AKICGJFMMLDJNPNMHPCEMOCEIEOPPFOEBENPBLNOOLJAIANINKONHDICL
MNNNNNEHCHBPPKEAGCFLHJNHJBAHFHAFPKPFCMNLMKJIPFNKAHFHAHIKL
APBBBPAPBDNAEBFGNNCKCIIFAHFCHHCAONFFPKOGOLMHNLNFEDFCGBKHH
HHHHHHHPHPPPHPPHHHHPPHPPPHPPPPPPPPPHHPHPPHHHPHPHHHHHPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

*176628528* Page 5 of 5